Abstract

Revolutionize Your Cancer Research With Next-Generation Models

Mindy Goldsborough, Chief Scientific Officer, ATCC

While current in vitro models for cancer have been the backbone upon which decades of research and discovery have been built upon, there still exists a need within the research community for more advanced models.  ATCC is tackling this challenge head-on.  Through both internal R&D, as well as participation in consortia such as the Human Cancer Models Initiative, ATCC is delivering a wide variety of next-generation cancer models to the research community. These advanced models include CRISPR gene edited cell lines and 3D models annotated with clinical and genomic data to promote rapid scientific advancements toward understanding, treating, and curing cancer.